Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $221.10, with a market capitalization of 31.66B. The stock trades at a price-to-earnings (P/E) ratio of -136.09.
On 2026-06-01, Natera(NTRA) stock traded between a low of $216.60 and a high of $225.10. Shares are currently priced at $221.10, which is +2.1% above the low and -1.8% below the high.
Natera(NTRA) shares are trading with a volume of 697.75K, against a daily average of 1.7M.
In the last year, Natera(NTRA) shares hit a 52-week high of $256.36 and a 52-week low of $131.81.
In the last year, Natera(NTRA) shares hit a 52-week high of $256.36 and a 52-week low of $131.81.
NTRA News
The United States market has experienced a notable upswing, climbing 1.6% in the last week and rising 28% over the past year, with earnings expected to grow by...
The United States market has shown robust performance, climbing 1.8% over the last week and 28% in the past year, with earnings forecasted to grow by 17% annual...
Why Natera Is My Favorite Stock Idea for the Rest of 2026 By Joey Frenette Published May 29, 10:26AM EDT Quick Read Stocks: Natera (NTRA) applies AI to cell-f...
Analyst ratings
90%
of 20 ratingsMore NTRA News
Natera (NTRA) announced a new collaboration with Diakonos Oncology Corp., a clinical-stage biotechnology company developing immunotherapies to treat challenging...
Natera (NTRA) announced enrollment of the first patients in SIgnatera-Guided iNterventionAL-ER 101, a prospective, single-arm, multi-center study evaluating Sig...
Natera, Inc. recently enhanced its Panorama non-invasive prenatal test with SNP-informed deep sequencing, showing strong performance even in low fetal fraction...
Natera (NasdaqGS:NTRA) announced a major upgrade to its Panorama non-invasive prenatal test that targets long-standing issues with low fetal fraction samples....
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.